CLINICAL PHENOTYPES OF BRONCHOPULMONARY DYSPLASIA: IMPLICATIONS FOR DIAGNOSIS AND TREATMENT
Abstract
Bronchopulmonary dysplasia (BPD) represents a highly prevalent chronic respiratory disease affecting preterm infants, frequently resulting in persistent respiratory impairment and long-term sequelae. Even among infants presenting with similar perinatal risk factors, the clinical manifestations and complications of BPD exhibit considerable variability. Such variability reflects the complex interaction of multiple injurious factors—varying in nature, timing, duration, and severity—to which the immature lungs are exposed. Furthermore, genetic and epigenetic factors modulate the response to initial lung injury, thereby yielding individualized patterns of pulmonary damage and repair.The extent to which pathological factors affect alveolar development, the interstitial compartment, proximal and distal airways, and the pulmonary vasculature similarly exhibits heterogeneity among preterm infants with BPD. This multifactorial pathogenesis, combined with individual patterns of injury and repair in the immature lung, contributes to the development of distinct clinical BPD phenotypes, each potentially associated with divergent long-term outcomes. Current therapeutic approaches remain largely nonspecific and frequently fail to adequately account for this phenotypic heterogeneity, thereby limiting their clinical efficacy.The identification and characterization of BPD phenotypes are thus essential for improving risk stratification and developing more individualized therapeutic strategies. This review summarizes current concepts regarding BPD phenotypes and their clinical characteristics, highlighting the importance of timely phenotype recognition as a basis for personalized and effective management of affected infants and children.